Share of high-value-added products in pharmaceutical exports (half year)

Proportion of high-value-added products such as chemical preparations and biological products in total pharmaceutical exports.

Unit Percent Industry Pharmaceuticals

Records
1
Regions
1
Period
2026
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Update cycle: irregular

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Share of high-value-added products in pharmaceutical exports (half year)

China, as of 30 Jun 2026

1 observation
20% China · as of 30 Jun 2026 · MOFCOM · full record
Source: MOFCOM · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2026

Share of high-value-added products in pharmaceutical exports (half year): every record, grouped by region, newest first.
Period Value Source Type
China 1 record
as of 30 Jun 2026 20% MOFCOM · 30 Jun 2026 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
上半年我国创新药对外技术授权交易额创新高 MOFCOM 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Share of high-value-added products in pharmaceutical exports (half year). Retrieved from https://statorigin.org/indicators/share-of-high-value-added-products-in-pharmaceutical-exports-half-year